VivoSeq
Other

Antibiotic Prophylaxis

0

Pipeline Programs

14

Active Trials

0

Companies Involved

Antibiotic Prophylaxis is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

31/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

84/100

Attrition Rate

9/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

76

clinical trials

Completed38 · 50%
Unknown status17 · 22%
Recruiting7 · 9%
Terminated5 · 7%
Not yet recruiting4 · 5%
Enrolling by invitation2 · 3%
Other3 · 4%

Trial Activity

76 trials

Antibiotic Prophylaxis for Bladder Botox
Recruiting·UUniversity of Alberta·Phase 4·NCT04444440·202 enrolled
Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery
Recruiting··Phase 3·NCT05502380·1,100 enrolled
Antibiotic Prophylaxis in Rhinoplasty
Enrolling by invitation·SStanford University·Phase 3·NCT04194216·864 enrolled
Antibiotic Prophylaxis in Pediatric Open Fractures
Enrolling by invitation·SSt. Louis University·Phase 4·NCT06055712·800 enrolled
Page 1 of 6

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)